miR-7 Reverses Breast Cancer Resistance To Chemotherapy By Targeting MRP1 And BCL2

miR-7 Reverses Breast Cancer Resistance To Chemotherapy By Targeting MRP1 And BCL2

Tianzi Hong,1 Jian Ding,2 Wenlian Li2 1Department of Thyroid and Breast Surgery, Jinjiang Hospital of Quanzhou Medical College, Jinjiang 362200, People’s Republic of China; 2Department of Breast Surgery, Zhongshan Hospital of Xiamen University, Xiamen 361004, People’s Republic of...

Full description

Bibliographic Details
Main Authors:	Hong T, Ding J, Li W
Format:	Article
Language:	English
Published:	Dove Medical Press 2019-12-01
Series:	OncoTargets and Therapy
Subjects:	mir-7 breast cancer pathological complete response chemoresistance mrp1 bcl2
Online Access:	https://www.dovepress.com/mir-7-reverses-breast-cancer-resistance-to-chemotherapy-by-targeting-m-peer-reviewed-article-OTT

Similar Items

Linc00518 Contributes to Multidrug Resistance Through Regulating the MiR-199a/MRP1 Axis in Breast Cancer
by: Liang Chang, et al.
Published: (2018-07-01)

LncRNA SNHG7 Mediates the Chemoresistance and Stemness of Breast Cancer by Sponging miR-34a
by: Zhi-hua Li, et al.
Published: (2020-11-01)

ALKBH5 inhibited autophagy of epithelial ovarian cancer through miR-7 and BCL-2
by: Hongtao Zhu, et al.
Published: (2019-04-01)

The Function Role of miR-181a in Chemosensitivity to Adriamycin by Targeting Bcl-2 in Low-Invasive Breast Cancer Cells
by: Ying Zhu, et al.
Published: (2013-11-01)

Lactate-induced MRP1 expression contributes to metabolism-based etoposide resistance in non-small cell lung cancer cells
by: Qi Dong, et al.
Published: (2020-10-01)

Bax, Bcl-2, and Bax/Bcl-2 as prognostic markers in acute myeloid leukemia: are we ready for Bcl-2-directed therapy?
by: Kulsoom B, et al.
Published: (2018-03-01)

miR-185-5p response to usnic acid suppresses proliferation and regulating apoptosis in breast cancer cell by targeting Bcl2
by: Elif Değerli, et al.
Published: (2020-05-01)

ATPase copper transporter A, negatively regulated by miR‐148a‐3p, contributes to cisplatin resistance in breast cancer cells
by: Ze Yu, et al.
Published: (2020-03-01)

miR‐140‐3p inhibits colorectal cancer progression and its liver metastasis by targeting BCL9 and BCL2
by: Dingsheng Liu, et al.
Published: (2021-05-01)

Regulation of MRP4 Expression by circHIPK3 via Sponging miR-124-3p/miR-4524-5p in Hepatocellular Carcinoma
by: Haihong Hu, et al.
Published: (2021-04-01)

LncRNA-SNHG7 Enhances Chemotherapy Resistance and Cell Viability of Breast Cancer Cells by Regulating miR-186
by: Zhang H, et al.
Published: (2020-10-01)

miR-206 as a prognostic and sensitivity biomarker for platinum chemotherapy in epithelial ovarian cancer
by: Xiaotang Yu, et al.
Published: (2020-11-01)

CORRELATION BETWEEN CHEMOTHERAPY RESPONSE AND EXPRESSION PROFILES OF TRANSMEMBRANE PROTEINS: P-GLYCOPROTEIN (ABCB1), MRP2 (ABCC2), BCRP (ABCG2) IN PATIENTS WITH INVASIVE BREAST CANCER
by: К. Yu. Khristenko, et al.
Published: (2016-10-01)

Silencing of circHIPK3 Sensitizes Paclitaxel-Resistant Breast Cancer Cells to Chemotherapy by Regulating HK2 Through Targeting miR-1286
by: Ni J, et al.
Published: (2021-07-01)

MEK inhibition induced downregulation of MRP1 and MRP3 expression in experimental hepatocellular carcinoma
by: Lin Shibo, et al.
Published: (2013-01-01)

Long Non-coding RNA BLACAT1 Induces Tamoxifen Resistance in Human Breast Cancer by Regulating miR-503/Bcl-2 Axis
by: Qu R, et al.
Published: (2020-03-01)

Therapeutic Potential of Chemically Modified miR-489 in Triple-Negative Breast Cancers
by: Young Hwa Soung, et al.
Published: (2020-08-01)

MiR-429 Induces Gastric Carcinoma Cell Apoptosis Through Bcl-2
by: Ping Zhu, et al.
Published: (2015-10-01)

miR-613 Suppresses Chemoresistance and Stemness in Triple-Negative Breast Cancer by Targeting FAM83A
by: Liu C, et al.
Published: (2020-12-01)

MODELOS DE SISTEMAS MRP CERRADOS INTEGRANDO INCERTIDUMBRE MODELOS DE SISTEMAS MRP FECHADOS INTEGRANDO INCERTEZA CLOSED MODELS OF MRP SYSTEMS CONSIDERING UNCERTAINTIES
by: Martín Dario Arango, et al.
Published: (2012-12-01)

ABT-737 reverses the acquired radioresistance of breast cancer cells by targeting Bcl-2 and Bcl-xL
by: Li Ji-Yu, et al.
Published: (2012-12-01)

Stratégie d'éradication de cellules cancéreuses chimiorésistantes surexprimant le transporteur de drogues MRP1 par des composés activateurs de son activité d’efflux de glutathion
by: Dury, Lauriane
Published: (2015)

Eradication ciblée des cellules cancéreuses chimiorésistantes par des activateurs du transporteur de drogues MRP1 : mécanismes moléculaires et cellulaires
by: Lorendeau, Doriane
Published: (2012)

Effect of bile acids on the expression of MRP3 and MRP4: An In vitro study in HepG2 cell line
by: Suilma Ivette Pérez-Pineda, et al.
Published: (2021-09-01)

MiR-4328 inhibits proliferation, metastasis and induces apoptosis in keloid fibroblasts by targeting BCL2 expression
by: Tang Hongmei, et al.
Published: (2020-09-01)

MiR-137 Suppresses Triple-Negative Breast Cancer Stemness and Tumorigenesis by Perturbing BCL11A-DNMT1 Interaction
by: Feiyu Chen, et al.
Published: (2018-07-01)

miR-let-7b and miR-let-7c suppress tumourigenesis of human mucosal melanoma and enhance the sensitivity to chemotherapy
by: Huan Tang, et al.
Published: (2019-05-01)

Psoralen Suppresses Cisplatin-Mediated Resistance and Induces Apoptosis of Gastric Adenocarcinoma by Disruption of the miR196a-HOXB7-HER2 Axis
by: Jin L, et al.
Published: (2020-04-01)

Potential Biomarkers for Treatment Response to the BCL-2 Inhibitor Venetoclax: State of the Art and Future Directions
by: Haneen T. Salah, et al.
Published: (2021-06-01)

Establishment and Characterization of a Novel Multidrug Resistant Human Ovarian Cancer Cell Line With Heterogenous MRP7 Overexpression
by: Jing-Quan Wang, et al.
Published: (2021-09-01)

Bcl-2 Family Proteins in Development and Treatment of Malignant Diseases
by: Racay P., et al.
Published: (2011-12-01)

miR-206 regulates 5-FU resistance by targeting Bcl-2 in colon cancer cells
by: Meng X, et al.
Published: (2018-03-01)

miR‐15b enhances the proliferation and migration of lung adenocarcinoma by targeting BCL2
by: Jun Wang, et al.
Published: (2020-06-01)

Evaluation of the effect of liposomal miR-143 on cell viability and anti-apoptotic gene expression of Bcl-2 in human osteosarcoma cells for the treatment of metastatic cancers
by: fatemeh Barzegari firouzabadi, et al.
Published: (2018-10-01)

miR-149 inhibits cell proliferation and enhances chemosensitivity by targeting CDC42 and BCL2 in neuroblastoma
by: Fengxia Mao, et al.
Published: (2019-12-01)

Diagnostic and Prognostic Value of Calprotectin (MRP8/MRP14) in the Blood of Patients with Different Types of Juvenile Idiopathic Arthritis
by: Ya.Ye. Boiko
Published: (2016-10-01)

From Christian Social Order to Humane Democracy Three Itineraries Leading to the MRP 1936-1948
by: Arthur Plaza
Published: (2005-12-01)

Insights on the structure–function relationship of human multidrug resistance protein 7 (MRP7/ABCC10) from molecular dynamics simulations and docking studies
by: Jing‐Quan Wang, et al.
Published: (2021-06-01)

The role of estrogen receptor alpha in mediating chemoresistance in breast cancer cells
by: Jiang Zhinong, et al.
Published: (2012-05-01)

MiR-223 regulates autophagy associated with cisplatin resistance by targeting FBXW7 in human non-small cell lung cancer
by: Hui Wang, et al.
Published: (2020-06-01)

Cannot write session to /tmp/vufind_sessions/sess_svnr65nlao5mfj8akoc8623v59